A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M\u2122 \u2013 which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.\r\n\r\nIn their findings (reported in The Lancet Infectious Diseases), they found that a vaccine booster dose at one year following a primary three-dose regime maintained high efficacy against malaria, and continued to meet the World Health Organization\u2019s Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75% efficacy.
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
PSI Director Professor Sir Peter Horby explains how relationships across scientific disciplines, sectors and global regions are key to preventing and preparing for future pandemics.
Representatives from academia, industry, policy and civil society are gathering in Oxford next week to discuss the latest scientific advances that are ensuring the world is better prepared for future pandemics.
PSI Director Professor Sir Peter Horby today gave evidence at the House of Commons\u2019 Science, Innovation and Technology Select Committee Inquiry on Emerging Diseases and Learnings from COVID-19.
Oxford Vaccine Group and Pandemic Sciences Institute\u2019s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
Abstract submission for the International Pandemic Sciences Conference 2023 - Making the Exceptional Routine has been extended to Friday 28 April 2023.
A new Future Vaccines Manufacturing Hub \u2013 co-led by University of Oxford and University College London \u2013 aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
Professor Dame Sarah Gilbert has been awarded the prestigious King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.
A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.
The Pandemic Sciences Institute announces a new partnership with the Royal Veterinary College to facilitate collaborative research into infectious diseases.
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Professor Dame Sarah Gilbert, the Sa\u00efd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.
Here at VaccineNation we are delighted to kickstart the new year with another one of our recorded interviews from the World Vaccine Congress in Europe. As we look forward to the Congress in Washington in April, we will be releasing further interviews and exploring key themes for the event. For this interview we were lucky to secure a slot with Professor Miles Carroll of Oxford University. A specialist in high consequence emerging viral infections, his insight into how we respond to new threats and prepare for the future is incredibly exciting!
During the first lockdown in early 2020, an emergency Coronavirus Research Fund was set up to channel the huge amounts of gifts that started pouring in, and to direct them quickly to the research projects that had the biggest chance of mitigating the worst effects of the pandemic.
![\"\"](\"https://www.cbf.ox.ac.uk/news/clinical-trial-for-crimean-congo-haemorrhagic-fever-vaccine-launched/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n